mHealth Market
Get a free sample of this report
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Request Sectional Data
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
mHealth Market size was valued at more than USD 111.5 billion in 2022 and is expected to observe over 22% CAGR through 2032.
Increasing incidences of chronic diseases, including diabetes is expected to boost the market penetration in developed regions of North America and Europe. Digital innovations, such as mobile health (mHealth) are being used to provide effective healthcare to the users. A recent survey finding revealed that nearly 44% of the U.S. consumers presently use a digital tool to track some aspect of their health. The easy accessibility of these applications and devices is also a key force accelerating the market development.
| Report Attribute | Details |
|---|---|
| Base Year: | 2022 |
| mHealth Market Size in 2022: | USD 111.5 Billion |
| Forecast Period: | 2023 to 2032 |
| Forecast Period 2023 - 2032 CAGR: | 22 |
| 2023 Value Projection: | USD 888.5 Billion |
| Historical Data for: | 2018 to 2022 |
| No of Pages: | 350 |
| Tables, Charts & Figures: | 479 |
| Segments Covered: | Platform, Application, End-use, and Region. |
| Growth Drivers: |
|
| Pitfalls Challenges: |
|
The implementation of mHealth solutions requires full-proof data security, without which the physicians and hospitals business is at stake, as they incur huge losses of critical and confidential information. It adversely affects the reputation and results of operations. Smartphones and mHealth applications are exposed to a wide range of security threats due to their portability and weaknesses in management and design. These factors may cause a hinderance to the industry expansion.
mHealth market from the wearable devices product segment is expected to cross USD 171 billion through 2032. The notable revenue share is attributed to multiple prime advantages offered by the product, including better accessibility to clinical information. The COVID-19 pandemic had a positive influence on the wearable devices demand, as the need to monitor vital healthcare parameters regularly surged significantly. As per some estimates, about one-fifth of the U.S. population wore a smart wearable technology in 2021. Adequate application of wearable devices in measuring and overviewing the heart health, physical attributes, blood glucose levels, temperature, and medication compliance among others would further drive their adoption.
Global mHealth Market Share, By Application, 2022 (%) | |
Segment | Global market share |
| Communication and Training | 5.39% |
| Education and Awareness | 7.02% |
| Diagnostics and Treatment | 24.08% |
| Disease and Epidemic Outbreak Tracking | 11.36% |
| Remote Data Collection | 8.86% |
| Remote Monitoring | 40.55% |
| Others | 2.74% |
mHealth market from diagnostics and treatment application segment is anticipated to grow at more than 21% CAGR through 2032. This is attributed to the rising prevalence of various chronic conditions. Patients suffering from cardiovascular diseases, diabetes, and neurological disorders, require real-time monitoring of their health conditions. Catering to needs of this growing patient pool, Peerbridge Health designed the Peerbridge Cor System that offers portable ECG diagnostics. The FDA regulated wearable modality targets AFib along with other arrhythmias. Such notable developments by leading companies are set to drive the segment expansion.
mHealth market from the patients’ segment is projected to reach USD 190.5 billion by 2032. The considerable revenue share is majorly attributed to the increasing awareness among individuals for regulating vital parameters including body temperature, heart health, mental wellbeing, sleep duration, and physical fitness. Moreover, the growing emphasis on mHealth due to quick internet access will accelerate the product adoption.
Asia Pacific mHealth market was valued at more than USD 32.5 billion in 2022 and is anticipated to showcase over 23% CAGR through 2032. The regional healthcare industry is moving toward digitization of their operations in a bid to improve the patient experience. With 76% of healthcare practitioners in the nation presently utilizing DHRs in their operations, India is a forerunner in the adoption of digital health technologies. Various governments in the continent are expected to launch multiple mHealth related solutions in the future, thereby augmenting the regional market statistics.
are some of the renowned companies offering advanced mHealth products and services. To unlock the rising consumer demand and supply equilibrium, these players are increasing their investments in R&D activities and launching new and improved products.
mHealth apps have played an instrumental role in mitigating the COVID-19 response across the globe. During the first wave of the pandemic, significant adoption of mHealth apps was observed for the management of COVID-19, including contact tracing, and information providing applications. Various mHealth apps were developed as a result of tackling the virus, such as symptom monitoring to combat the disease outbreak.
By Platform
By Application
By End-use
The above information is provided for the following regions and countries:
Global market size for mHealth was valued at more than USD 111.5 billion in 2022 and is expected to observe over 22% CAGR through 2032, owing to the increasing incidence of chronic diseases such as diabetes across the globe.
Allscripts Healthcare Solutions, AT&T, Athenahealth, Inc., Samsung Electronics Corporation, Apple Inc., Koninklijke Philips.V., Omron Healthcare Inc., Bayer Healthcare, Boston Scientific Corporation, Qualcomm Inc., Sanofi SA, PLUX Wireless Biosignals S.A., and AliveCor Inc are some of the key mHealth companies.
Asia Pacific mHealth market was valued at more than USD 32.5 billion in 2022 and is anticipated to showcase over 23% CAGR through 2032, with growing utilization of digital health records (DHRs) in the healthcare sector of the region.
Wearable devices segment is expected to cross USD 171 billion through 2032, pertaining to multiple prime advantages offered by the product, including better accessibility to clinical information.